NASDAQ
CG Oncology, Inc. Common stock (CGON) has a price/sales ratio of 794.47x as of Friday, May 22, 2026. This represents a 88.20% decrease compared to its 12-month average of 6730.55x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.